A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Maternal asthma during pregnancy and the likelihood of neurodevelopmental disorders in offspring
Tekijät: Kemppainen, Mari; Gissler, Mika; Kirjavainen, Turkka
Kustantaja: WILEY
Kustannuspaikka: HOBOKEN
Julkaisuvuosi: 2025
Journal: Acta Obstetricia et Gynecologica Scandinavica
Tietokannassa oleva lehden nimi: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
Lehden akronyymi: ACTA OBSTET GYN SCAN
Vuosikerta: 104
Numero: 1
Aloitussivu: 235
Lopetussivu: 244
Sivujen määrä: 10
ISSN: 0001-6349
eISSN: 1600-0412
DOI: https://doi.org/10.1111/aogs.15008
Verkko-osoite: https://obgyn.onlinelibrary.wiley.com/doi/10.1111/aogs.15008
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/477909530
Introduction: Asthma is the most common chronic disease during pregnancy. Maternal asthma has been associated with a multitude of unwanted pregnancy outcomes, in some studies also with neurodevelopmental disorders. Here we investigated associations between maternal asthma and neurodevelopmental disorders.
Material and Methods: We studied a retrospective population-based cohort of 1 271 439 mother-child pairs from singleton live births in Finland between the years 1996-2018. We used multiple high-cover registers for data collection. Adjusted unconditional Cox regression models were used to investigate associations between maternal asthma, asthma medication used during pregnancy, and offspring's neurodevelopmental disorder diagnoses.
Results: We identified 106 163 mother-child pairs affected by maternal asthma. We found that maternal asthma was associated with offspring neurodevelopmental disorders, but the differences in absolute prevalence between the control and exposure groups were small. Attention-deficit hyperactivity disorder (ADHD) was found in 4114 (3.9%) offspring with maternal asthma and in 32 122 (3.0%) controls (adjusted hazard ratio (HR): 1.49; 95% CI 1.44-1.54); autism in 1617 (1.5%) offspring versus 13 701 (1.3%) controls (HR: 1.33; 95% CI 1.26-1.40); motor-developmental disorder in 1569 (1.5%) offspring versus 12 147 (1.1%) controls (HR: 1.37; 95% CI 1.30-1.45); language disorder in 3057 (2.9%) offspring versus 28 421 (2.7%) controls (HR: 1.13; 95% CI 1.08-1.17), learning disabilities in 849 (0.8%) offspring versus 6534 (0.6%) controls (HR: 1.51; 95% CI 1.41-1.62); mixed developmental disorder in 1633 (1.5%) offspring versus 14 434 (1.3%) controls (HR 1.20; 95% CI, 1.14-1.26); and intellectual disability in 908 (0.9%) versus 9155 (0.9%) controls (HR: 1.12; 95% CI 1.04-1.20). No substantial differences were found between allergic and non-allergic asthma phenotypes, and neither allergic tendency nor respiratory infection was associated with a similar likelihood of neurodevelopmental disorders.
Conclusions: Maternal asthma and allergic and non-allergic phenotypes showed weak associations with the offspring's neurodevelopmental disorders. The association is concerned especially with learning disabilities, ADHD, motor development, and autism.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
This study was supported by grants from the Foundation for Pediatric Research in Finland as a group grant to TK (#160268, #190140, #200184). MK received funds from the State research fund and Tampere Tuberkuloosisäätiö foundation. The State research fund is granted by the Finnish state based on both scientific evaluation and evaluation of health benefits. The Foundation for Pediatric Research and Tampere Tuberkuloosisäätiö foundation are independent charity organizations committed to pediatric and pulmonary health improvement, respectively. MG was funded by FLUX Consortium ‘Family Formation in Flux—Causes, Consequences and Possible Futures, by the Strategic Research Council, Research Council of Finland (DEMOGRAPHY 345130).